Cargando…

Correction: Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia

Detalles Bibliográficos
Autores principales:	Narlik-Grassow, Maja, Blanco-Aparicio, Carmen, Cecilia, Yolanda, Perez, Marco, Muñoz-Galvan, Sandra, Cañamero, Marta, Renner, Oliver, Carnero, Amancio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654824/ http://dx.doi.org/10.1371/annotation/1b8b6002-4e0f-4c5d-8ae8-fd45447b6149

Ejemplares similares

Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
por: Narlik-Grassow, Maja, et al.
Publicado: (2013)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
por: Jiménez-García, Manuel-Pedro, et al.
Publicado: (2017)

Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens
por: Aguirre, Enara, et al.
Publicado: (2014)

Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models
por: Blanco-Aparicio, Carmen, et al.
Publicado: (2010)

PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2021)

Expression and ERG regulation of PIM kinases in prostate cancer
por: Eerola, Sini K., et al.
Publicado: (2021)

Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis
por: Moneo, Victoria, et al.
Publicado: (2014)

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC
por: Moore, Gillian, et al.
Publicado: (2021)

Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts
por: Santio, Niina M., et al.
Publicado: (2015)

PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells
por: Santio, Niina M., et al.
Publicado: (2016)

Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
por: Wang, Jie, et al.
Publicado: (2010)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

A review on PIM kinases in tumors
por: Arrouchi, Housna, et al.
Publicado: (2019)

PIM Kinase as an Executional Target in Cancer
por: Zhang, Xinning, et al.
Publicado: (2018)

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
por: Mohlin, Sofie, et al.
Publicado: (2020)

Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics
por: Wang, Yixin, et al.
Publicado: (2021)

PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2014)

Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
por: Wang, Jie, et al.
Publicado: (2011)

The Role of PIM Kinases in Pediatric Solid Tumors
por: Julson, Janet Rae, et al.
Publicado: (2022)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
por: Clements, Amber N., et al.
Publicado: (2022)

[Retracted] Expression and function of PIM kinases in osteosarcoma
por: Mou, Shuai, et al.
Publicado: (2023)

Pim Kinases: Important Regulators of Cardiovascular Disease
por: Nock, Sophie, et al.
Publicado: (2023)

PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism
por: Serrano-Saenz, Santiago, et al.
Publicado: (2019)

Hierarchical Control on Polyene Macrolide Biosynthesis: PimR Modulates Pimaricin Production via the PAS-LuxR Transcriptional Activator PimM
por: Santos-Aberturas, Javier, et al.
Publicado: (2012)

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
por: Santio, Niina M, et al.
Publicado: (2010)

PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023)

PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells
por: Siu, Allan, et al.
Publicado: (2011)

The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status
por: Trigg, Ricky M., et al.
Publicado: (2019)

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
por: Perez, Marco, et al.
Publicado: (2015)

The Pim kinases control rapamycin-resistant T cell survival and activation
por: Fox, Casey J., et al.
Publicado: (2005)

Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor
por: Bullock, Alex N., et al.
Publicado: (2009)

Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice
por: An, Ningfei, et al.
Publicado: (2013)

Pim1 kinase regulates c-Kit gene translation
por: An, Ningfei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6kku4saf83kpdl3q6m3astdsp2